| Survey of unlicensed and off label drug use in paediatric wards in European countries S Conroy, I Choonara, P Impicciatore, A Mohn, H Arnell, A Rane, ... bmj 320 (7227), 79-82, 2000 | 1067 | 2000 |
| Neonatal drug withdrawal ML Hudak, RC Tan, Committee on Drugs, ... Pediatrics 129 (2), e540-e560, 2012 | 1043 | 2012 |
| Cytochrome P450 3A: ontogeny and drug disposition SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 37, 485-505, 1999 | 707 | 1999 |
| The transfer of drugs and therapeutics into human breast milk: an update on selected topics HC Sachs, Committee on Drugs, DAC Frattarelli, JL Galinkin, TP Green, ... Pediatrics 132 (3), e796-e809, 2013 | 575 | 2013 |
| An antibiotic policy to prevent emergence of resistant bacilli P De Man, BAN Verhoeven, HA Verbrugh, MC Vos, JN Van den Anker The Lancet 355 (9208), 973-978, 2000 | 519 | 2000 |
| Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations IH Bartelink, CMA Rademaker, AFAM Schobben, JN Van Den Anker Clinical pharmacokinetics 45, 1077-1097, 2006 | 500 | 2006 |
| Glucuronidation in humans: pharmacogenetic and developmental aspects SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 36, 439-452, 1999 | 480 | 1999 |
| More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012 | 433 | 2012 |
| Impact of obesity on drug metabolism and elimination in adults and children MJE Brill, J Diepstraten, A van Rongen, S Van Kralingen, ... Clinical pharmacokinetics 51, 277-304, 2012 | 414 | 2012 |
| CYP3A5 Variant Allele Frequencies in Dutch Caucasians RHN van Schaik, IP van der Heiden, JN van den Anker, J Lindemans Clinical chemistry 48 (10), 1668-1671, 2002 | 402 | 2002 |
| Off-label use of drugs in children Committee on Drugs, KA Neville, DAC Frattarelli, JL Galinkin, TP Green, ... Pediatrics 133 (3), 563-567, 2014 | 377 | 2014 |
| Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial SHP Simons, M Van Dijk, RA van Lingen, D Roofthooft, ... Jama 290 (18), 2419-2427, 2003 | 348 | 2003 |
| Developmental changes in pharmacokinetics and pharmacodynamics J van den Anker, MD Reed, K Allegaert, GL Kearns The Journal of Clinical Pharmacology 58, S10-S25, 2018 | 292 | 2018 |
| Early inhaled budesonide for the prevention of bronchopulmonary dysplasia D Bassler, R Plavka, ES Shinwell, M Hallman, PH Jarreau, V Carnielli, ... New England Journal of Medicine 373 (16), 1497-1506, 2015 | 281 | 2015 |
| Rising opioid prescribing in adult US emergency department visits: 2001–2010 M Mazer‐Amirshahi, PM Mullins, I Rasooly, J van den Anker, JM Pines Academic Emergency Medicine 21 (3), 236-243, 2014 | 205 | 2014 |
| The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants GP Heresi, DR Gerstmann, MD Reed, JN van den Anker, JL Blumer, ... The Pediatric infectious disease journal 25 (12), 1110-1115, 2006 | 204 | 2006 |
| Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance BJ Anderson, K Allegaert, JN Van den Anker, V Cossey, NHG Holford British journal of clinical pharmacology 63 (1), 75-84, 2007 | 202 | 2007 |
| A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital GW 't Jong, AG Vulto, M de Hoog, KJM Schimmel, D Tibboel, ... Pediatrics 108 (5), 1089-1093, 2001 | 200 | 2001 |
| Morphine glucuronidation in preterm neonates, infants and children younger than 3 years CAJ Knibbe, EHJ Krekels, JN van den Anker, J DeJongh, GWE Santen, ... Clinical pharmacokinetics 48, 371-385, 2009 | 173 | 2009 |
| Efavirenz in the therapy of HIV infection NY Rakhmanina, JN Van den Anker Expert opinion on drug metabolism & toxicology 6 (1), 95-103, 2010 | 166 | 2010 |
karel allegaerthoogleraar geneeskunde, KU LeuvenDirección de correo verificada de uzleuven.be
